# Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Study · id `cardio:ct-nct05047172` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05047172](<https://clinicaltrials.gov/study/NCT05047172>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05047172

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1683 participants.

## Technical summary

Registry record NCT05047172. Randomized; quadruple masking; primary purpose prevention. Start 2022-08-02 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 1683 participants (planned count; ClinicalTrials.gov record NCT05047172, source copy `cardio:ctgov-nct05047172-2026-11-16`, retrieved 2026-11-18)
- Started: 2022-08-02 (actual) (ClinicalTrials.gov record NCT05047172, source copy `cardio:ctgov-nct05047172-2026-11-16`, retrieved 2026-11-18)
- Primary completion: 2027-01-31 (anticipated) (ClinicalTrials.gov record NCT05047172, source copy `cardio:ctgov-nct05047172-2026-11-16`, retrieved 2026-11-18)
- Completion: 2027-01-31 (anticipated) (ClinicalTrials.gov record NCT05047172, source copy `cardio:ctgov-nct05047172-2026-11-16`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT05047172, source copy `cardio:ctgov-nct05047172-2026-11-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05047172-2026-11-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
- Acronym: CAPTIVA
- Condition: Intracranial Arteriosclerosis
- Condition: Stroke
- Intervention (Drug): Ticagrelor + Aspirin
- Intervention (Drug): Rivaroxaban + Aspirin
- Intervention (Drug): Clopidogrel + Aspirin
- Intervention (Other): Risk Factor Management
- Lead sponsor: University of Florida
- Lead sponsor class: OTHER
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH
- Collaborator: University of Cincinnati
- Collaborator class: OTHER
- Collaborator: Medical University of South Carolina
- Collaborator class: OTHER
- Collaborator: Janssen Scientific Affairs, LLC
- Collaborator class: INDUSTRY
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Florida (`cardio:org-university-of-florida`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)
- Registry lists this organization as a collaborator: University of Cincinnati (`cardio:org-university-of-cincinnati`)
- Registry lists this organization as a collaborator: Medical University of South Carolina (`cardio:org-medical-university-of-south-carolina`)
- Registry lists this organization as a collaborator: Janssen Scientific Affairs, LLC (`cardio:org-janssen-scientific-affairs-llc`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

## Provenance

Content hash: ee20421c5cbfcd29b0759bad33738aa28b6ceecb0d224d597fbcbc8c71ff84bb
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
